Sanofi Facing DOJ Investigation Over Plavix Disclosures

Law360, New York (March 8, 2013, 6:10 PM EST) -- Federal officials are investigating French pharmaceutical giant Sanofi SA over its disclosures to the U.S. Food and Drug Administration about patient responses to the blood-thinning drug Plavix, the company revealed in a U.S. Securities and Exchange Commission filing Thursday.

Sanofi said in its annual report that the U.S. Department of Justice is conducting a probe of the drugmaker's statements to the FDA, which the company first learned about in June 2012. The pharmaceutical giant, which co-markets the drug with Bristol-Myers Squibb Co., said that it was...
To view the full article, register now.